Anxiety and mood (대한불안의학회지)

Korean Academy of Anxiety Disorders (대한불안의학회)
권호 표지

The Effects of Comorbid Anxiety Disorder and Substance use Disorder on Major Depressive Disorder

공존하는 불안장애와 물질사용장애가 주요우울증에 미치는 영향

  • Shin, Jae Hyun (Department of Psychiatry, Keimyung Universitiy School of Medicine) ;
  • Kim, Jung Bum (Department of Psychiatry, Keimyung Universitiy School of Medicine) ;
  • Jung, Sung Won (Department of Psychiatry, Keimyung Universitiy School of Medicine)
  • 신재현 (계명대학교 의과대학 정신과학교실) ;
  • 김정범 (계명대학교 의과대학 정신과학교실) ;
  • 정성원 (계명대학교 의과대학 정신과학교실)
  • Received : 2013.09.17
  • Accepted : 2013.10.04
  • Published : 2013.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Major depressive disorder causes significant dysfunction and disability. Many of depressed patients tend to have cormobid anxiety disorders, substance use disorders and personality disorders, and so on. In this study, we reviewed researches about the effects of comorbid anxiety disorder, substance use disorder on depressive symptoms, progress, treatment, etc. In addition, the latest knowledges related to treatment was reviewed. If the symptoms of anxiety disorder coexist, They leads to the deterioration of the course and has an adverse effect on treatment response. Comorbid substance use disorder, such as alcohol dependence, causes worsening of symptoms and progression, and a loss of therapeutic response. Therapeutic clinical guidelines and instructions to comorbid psychiatric disorders on major depressive disorder was not established clearly, but consensus-based or evidence-based studies will be necessary for treatment for comorbid psychiatric disorders on major depressive disorder.

Keywords

References

  1. Paul EG, Ronald CK, Howard GB, Stephanie AL, Sarah WL, Patricia AB, et al. The economic burden of depression in the United Sta-tes: How did it change between 1990 and 2000? J Clin Psychiatry 2003;64:1465-1475. https://doi.org/10.4088/JCP.v64n1211
  2. Organization for Economic Cooperation and Deelopment. Health at a glance [Serial online] 2011. OECD indicators Paris 2011 [cited 2012 Mar 5]; 4(2): avaliable from: URL:http://dx.doi.org/10.1787/health_clance-2011-en.
  3. American Psychiatric Association. Diagnstic and Statical Manual of Mental Disorder, text revision, 4th ed. Washington, American Psychiatric Association;2000.
  4. Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollone SD, War-den D. Comorbid psychiatric disorders in depressed outpatient: De-mographic and clinical features. J Affect Disord 2005;87:43-55. https://doi.org/10.1016/j.jad.2005.03.005
  5. Zimmerman M, Chelminski I, McDernut W. Major depressive disorder and axis I diagnostic comorbidity. J Clin Psyciatry 2002;63: 187-193. https://doi.org/10.4088/JCP.v63n0303
  6. Reiger DA, Rae DS, Narrow WE. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 1998;173(suppl34):24-28.
  7. Jung JW, Kim HC, Sakong JK, Sung HM, Jung SW, Lee EJ, et al. Suicidality in major depressive disorder: The impact of psychiatric comorbidity. J Korean Neuropsychiatr Assoc 2012;51:1-8.
  8. McDermut W, Mattia J, Zimmerman M. Comorbidity Burden and Its Impact on Psychosocial Morbidity in Depressed Outpatients. J Affect Disord 2001;65:289-295. https://doi.org/10.1016/S0165-0327(00)00220-2
  9. Forthofer MS, Kessler RC, Story AL, Gortlieb IH. The Effective of Psychiatric Disorders on The Probability and Timinig of First Marriage. J Health Soc Behav 1996;37:121-132. https://doi.org/10.2307/2137268
  10. Kessler RC, Foster C, Saunders W, Stagg P. The Social Consequens of Psychiatric Disorders. 1. The Effect of Educational attachment. Am J Psychiatry 1994;152:1026-1032.
  11. Kessler RC. Psychiatric comorbidity. In: Textbook in psychiatric epidemiology edited by Tsuang MT et al, Weiley-Liss, New York;1995. p.179-197.
  12. Zimmerman M, Mattia JI. Psychiatric diagnosis in clinical practice: Is cormobidity being missed? Compre Psychiatry 1999;40:182-191. https://doi.org/10.1016/S0010-440X(99)90001-9
  13. Kim JB, Jung SW. Recognition of anxiety disorders in depressed patients. Anxiety and Mood 2007;3:15-19.
  14. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19. https://doi.org/10.1001/archpsyc.1994.03950010008002
  15. Kessler RC, Nelson CB, Mcgonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-r major depressive disroder in the general population. Results from the US National Comorbidity Survey. Br J Psychiatry 1996;168(suppl30):17-30.
  16. Deborah SH, Renee DG, Frederick SS, Bridget FG. Epidemiology of major depressive disorder. Arch Gen Psychiatry 2005;62:1097-1106. https://doi.org/10.1001/archpsyc.62.10.1097
  17. Gaynes BN, Magruder KM, Burns BJ, Wagner HR, Yarnall KSH, Broadhead WE. Does a coexisting anxiety disorder predict persistence of depressive illness in a primary care patients with major depression?. Gen Hop Psychiatry 1992;21:158-167.
  18. Petterson T, Andreotti CF, Chelminski I, Young D, Zimmerman M. Do comorbid anxiety disorders impact treatment planning for outpatients with major depresive disorder?. Psychiatry research 2009; 169:7-11. https://doi.org/10.1016/j.psychres.2008.10.036
  19. Cyranowski JM, Schott LL, Kravitz HM, Brown C, Thurston RC, Joffe H, et al. Psychosocial features associated with lifetime comorbidity of major depression and anxiety disorders among a community smaple of midlife women: the swan mental health study Depress Anxiety 2012;29:1050-1057. https://doi.org/10.1002/da.21990
  20. Coyrell W, Endicott J, Andreasen NC. Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry 1988;145:293-300. https://doi.org/10.1176/ajp.145.3.293
  21. Kessler RC, Stang PE, Wittchen HU, Ustun TB, Roy-Burne PP, Walters EE. Lifetime panic-depression comorbidity in the national comorbidity survey. Arch Gen Pschiatry 1998;55:801-808. https://doi.org/10.1001/archpsyc.55.9.801
  22. Van Valkenburg C, Akiskal H, Puzantian V. Anxious depression: clinical, family history and naturalistic outcome comparisons with panic and major depressive disorders. J Affective Disord 1984;6:67-82. https://doi.org/10.1016/0165-0327(84)90009-0
  23. Keeler MB, Hanks DL. Anxiety symptom relief inn depression treatment outcomes. J Clin Psychiatry 1995:56:22-29.
  24. Fava M, Rankin MA, Wright E, Alpert JE, Nierenberg AA, Pava J. Anxiety disorders in major depression. Compr Psychiatry 2000;41: 97-102. https://doi.org/10.1016/S0010-440X(00)90140-8
  25. Schulberg HC, Block MR, Madonnia MJ, Scott CP, Rodrigeuz E, Imber SD, et al. Treating major depression in primary care practice: Eight month clinical outcomes. Arch Gen Psychiatry 1996;53:913-919. https://doi.org/10.1001/archpsyc.1996.01830100061008
  26. Levitt AJ, Joffe RT, Brecher D, MacDonald C. Anxiety disorders and anxiety symptoms in an clinic sample of seasonal and nonseasonal depressives. J Affect Disor 1993;28:51-56. https://doi.org/10.1016/0165-0327(93)90076-V
  27. Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum JF. Major depressive subtypes and treatment respones. Biological Psychiatry 1997;42:568-576. https://doi.org/10.1016/S0006-3223(96)00440-4
  28. Brown C, Schulber HC, Madonia MJ, Shear MK, Houck PR. Treatment outcomes for primary care patients with majoe depression and lifetime anxiety disorders. American J Psychiatry 1996:153:1293-1300. https://doi.org/10.1176/ajp.153.10.1293
  29. Lee T, Asam PL, Gersing KR, Chan E, Burchett BM, Sim K, et al. Prim Care Companion CNS Disord 2012; 14: doi: 10.4088/PCC.12m 0136.
  30. Nutt DJ. Care of depressed patients with anxiety symptoms. J Clin Pschiaty 1999;60(suppl):23-27.
  31. Pollack MH, Marzol PC. Pharmacotherapeutic options in the treatment of depression and anxiety. CNS Spectr 2000;5:23-30.
  32. Gorman JM, Liebowitz MR, Fyer AJ, Goetz D, Campeas D, Fyer MR, et al. An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 1987;7:329-332.
  33. Hoehn-Saric R, Ninan P, Black DW, Stahl S, Griest JH, Lydiard B, et al. Multicenter double-blind comparison or sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch Gen Psychiatry 2000;57:76-82. https://doi.org/10.1001/archpsyc.57.1.76
  34. Alan JG, Marlene PF, John CM, Jerrold FR, Michael ET, Madhukar HT, et al. Practice guideline for the treatment of patients with major depressive disorder. American Psychiatric Association;2010.
  35. Zimmerman M, Posternak M, Freidman, Attiullah N, Baymiller S, Boland R, et al. Which factors influence psychiatrust's selection of antidepressant? Am J Psychiatry 2004;161:1285-1289. https://doi.org/10.1176/appi.ajp.161.7.1285
  36. Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Al-cohol Depend 1995;39:197-206. https://doi.org/10.1016/0376-8716(95)01160-4
  37. Lori D, Akihito U, Jason MN, Elizabeth F. Major depression and comorbid substance use disorders. Current Opinion in Psychiatry 2008; 21:14-18. https://doi.org/10.1097/YCO.0b013e3282f32408
  38. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289:3095-3105. https://doi.org/10.1001/jama.289.23.3095
  39. Konsten TR, O'connor PG. Management of drug and alcohol withdrawl. N Engl J Med 2003:348:1786-1795. https://doi.org/10.1056/NEJMra020617
  40. Davis LL, Rush JA, Wisniewski SR. Substance use disroder cormobidity in major depressive disorder: An exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort. Compr Psychiatry 2005;46:81-89. https://doi.org/10.1016/j.comppsych.2004.07.025
  41. Burns L, Teeson M, O'Neill K. The impact of comorbid anxiety and dperession on alcohol treatment outcomes. Addiction 2005;100:787-796. https://doi.org/10.1111/j.1360-0443.2005.001069.x
  42. Hasin DS, Tsai WY, Endicott J. Five-year course of major depression: effects of comorbid alcoholism. J Affect Disord 1996;41:63-70. https://doi.org/10.1016/0165-0327(96)00068-7
  43. Cornelius JR, Salloum IM, Mezzich J. Disproportionate suicidality in patients with comorbid major depression and alcoholism. Am J Psychiatry 1995;152:358-364. https://doi.org/10.1176/ajp.152.3.358
  44. Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello LR, et al. The effect of depression on return to drinking: a prospective study. Arch Gen Pschiatry 1988;55:259-265.
  45. Davis LL, Fraixier E, Husain MM, Warden D, Teivedi M, Fava M, et al. Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort. Am J Addict 2006;15:278-285. https://doi.org/10.1080/10550490600754317
  46. Howland RH, Rush AJ, Wisniewki SR, Trivedi MH, Warden D, Fava M, et al. Concurrent anxiety and substance use disorders among outpatients with major depression. Drugs Alcohol Dependence 2009; 99:248-260. https://doi.org/10.1016/j.drugalcdep.2008.08.010
  47. Ford JD, Gelernter J, DeVoe JS, Zhang W, Weiss RD, Brady K, et al. Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utillization in cocaine- dependent indivisuals. Drug Alcohol Dependence 2009;99: 193-203. https://doi.org/10.1016/j.drugalcdep.2008.07.004
  48. Hasin D, Grant BF. Major depression in 6050 former drinkers: association with past alcohol dependence. Arch Gen Psychiatry 2002;59: 794-800. https://doi.org/10.1001/archpsyc.59.9.794
  49. Agosti V, Levin FR, The effects of alcohol and drug dependence on the course of depression. Am J Addict 2006;15:71-75. https://doi.org/10.1080/10550490500419102
  50. Kay-Lambkin FJ, Baker A, Carr VJ. Depression and drug and alcohol problem in Clinical handbook of coexisting mental health and drug and alcohol problems. ROutledge/Taylor & Francis group, New York, NY;2007. p.218-240.
  51. Watkins KE, Paddock SM, Zhang L, Wells KB. Improving care for depression in patients with comorbid substance misuse. Am J Pscyhiatry 2006;163:125-132. https://doi.org/10.1176/appi.ajp.163.1.125
  52. Hirschefeld RMA, Hasin D, Keller MB, Endicott J, Wunder J. Depression and alcoholism: Comorbidiy in a longitudinal study. In: Comorbidity of Mood and Anxiety Disorders. Edited by Maser JD & Cloninger CR, Washington, DC, APP;1990. p.293-304.
  53. Schukit MA. Genetic and clinical implication of alcoholism and affective disorder. Am J Psychiatry 1986;143:140-147. https://doi.org/10.1176/ajp.143.2.140
  54. Goodwin DW, Guze SB. "Psychiatric Diagnosis" 3rd Edition, New York, Oxford Universitiy Press;1984.
  55. Marks IM. Mental health care delivery: Innovations, impediment, and implementation. Cambridge, Cambridge University Press;1990.
  56. Buksteiin OG, Brent DA, Kamier Y. Comorbidity of substance abuse and other psychiatric disorders in adolescents. Am J Psychiatry 1989; 146:1131-1141. https://doi.org/10.1176/ajp.146.9.1131
  57. Oslin DW. Treatment of late-life depression complicated by alcohol dependence. Am J Geriatr Psychiatry 2005;13:491-500. https://doi.org/10.1097/00019442-200506000-00008
  58. Nunes EV, Levn FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 2004;291:1887-1896. https://doi.org/10.1001/jama.291.15.1887
  59. Sullivan LE, Fiellin DA, O'Connor PG. The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med 2005;118:330-341. https://doi.org/10.1016/j.amjmed.2005.01.007
  60. Partonen T, Sihvo L, Lonnqvist JK. Patients excluded from an antidepressant efficacy trial. J Clin Psychiatry 1996;57:572-575. https://doi.org/10.4088/JCP.v57n1203
  61. Torrens M, Fonseca F, Mateu G, Farre M. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug Alcohol Depend 2005; 78:1-22. https://doi.org/10.1016/j.drugalcdep.2004.09.004
  62. Serge B, Sybulle S, Jitender S, Jacques T, Christian GS, Roger SM, et al. The Canadian network for mood and anxiety treatments (CA-NMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorder. Ann Clin Psychiaty 2012;24:38-55.